ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 21 Nov 2022
Last Applicant/ Owned by
325 East Middlefield Road
Mountain View
CA
94043
Serial Number
88484182 filed on 21st Jun 2019
Registration Number
N/A
Correspondent Address
Karen Feisthamel
Filing Basis
1. intent to use
2. intent to use current
3. filed as use application
Disclaimer
NO DATA
Logo Mark Trademark Information
Pharmaceutical preparations and substances for the treatment metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, hepatological, ophthalmic, neurological, gastrointestinal, hormonal, dermatological, psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of blood disorders, pain, inflammation, sepsis, al Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations and substances for the treatment metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, hepatological, ophthalmic, neurological, gastrointestinal, hormonal, dermatological, psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders
Mark Details
Serial Number
No 88484182
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 8570.T0003
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.15.28 -
Miscellaneous designs with overall polygon shape
Legal History
| Status Date | Action Taken |
|---|---|
| 21st Nov 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| 21st Nov 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 19th Apr 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 19th Apr 2022 | CORRECTED NOA E-MAILED |
| 18th Apr 2022 | DIVISIONAL PROCESSING COMPLETE |
| 18th Apr 2022 | SOU EXTENSION 5 GRANTED |
| 15th Apr 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 31st Mar 2022 | SOU TEAS EXTENSION RECEIVED |
| 31st Mar 2022 | TEAS REQUEST TO DIVIDE RECEIVED |
| 31st Mar 2022 | DIVISIONAL REQUEST RECEIVED |